Johnson and Johnson is facing an unprecedented wave of asbestos-related cancer litigation following a series of landmark jury verdicts in late 2025, with cumulative awards now reaching historic levels.
A Baltimore jury awarded over $1.5 billion to a single plaintiff who developed mesothelioma after years of using J&J talc products—the largest single-plaintiff verdict against the company to date. The litigation threatens to define J&J's legal identity for a generation.
The Talc-Asbestos Connection
For decades, Johnson and Johnson marketed its talc-based baby powder and other consumer products as safe. Internal documents revealed during litigation show that company scientists detected traces of asbestos—a known carcinogen—in talc samples going back to the 1970s. The company consistently denied that its products contained asbestos and contested causation, arguing that plaintiffs' mesothelioma and ovarian cancer resulted from other exposures.
The Verdicts
In addition to the $1.5 billion Baltimore verdict, a California jury awarded $966 million to the family of a woman who died from mesothelioma linked to asbestos-contaminated talc, and a Los Angeles jury awarded $40 million to two women diagnosed with ovarian cancer. Johnson and Johnson has announced plans to appeal all major verdicts, calling them unconstitutional and contrary to the scientific evidence.
The Bankruptcy Strategy
J&J has attempted to use a controversial legal strategy known as the "Texas Two-Step"—creating a subsidiary to absorb talc liabilities and immediately filing it for bankruptcy—to channel all claims into a single bankruptcy proceeding and cap its total exposure. Courts have been deeply divided on whether this maneuver is permissible, and the litigation over the legality of the bankruptcy strategy remains ongoing in parallel with individual trials.
What 2026 Holds
Additional trials are scheduled throughout 2026 in multiple jurisdictions, with settlement discussions expected to accelerate given the scale of recent verdicts. Legal analysts estimate J&J's total talc liability exposure could range from $10 billion to $20 billion or more depending on court outcomes. The litigation has also catalyzed broader scrutiny of product safety in cosmetics and personal care products, accelerating FDA efforts to modernize cosmetic regulation.
Read next - Health
2026 measles outbreak | drug import tariffs | CDC testing pause | healthcare top concern | hearing gene therapy | cholesterol drug breakthrough | Title X funding | Iowa Medicaid tax | deep sleep hormone | BMI accuracy study
Science
Artemis II launch | forbidden black holes | Starship to Uranus | fusion plasma mystery | China R&D lead | dynamic DNA movement | quantum computer plan | magnetic field mystery | DNA robots medicine | ocean nanoplastics discovery
Birthright citizenship case | Section 230 lawsuits | Roundup cancer lawsuits | conversion therapy ruling | ISP copyright ruling | tariffs authority ruling | social media trials | Monsanto Supreme Court | talc asbestos verdicts | death penalty bias
Latest Reviews
Best Poison for Racoon |
Best Spy Camera Watch |
Best Bag for MGI Zip Navigator |
Best Low Level CO Detector |
Best Camera for MEVO Plus |
Best Sun Lamp for Tanning
